AURX
Price:
$2.26
Market Cap:
$108.66M
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
Industry
Biotechnology
IPO Date
2017-10-24
Stock Exchange
OTC
Ticker
AURX
According to Nuo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 1.03%. This represents a change of 795.02% compared to the average of 115.12% of the last 4 quarters.
The mean historical ROE of Nuo Therapeutics, Inc. over the last ten years is -147.61%. The current 1.03% ROE has changed -798.04% with respect to the historical average. Over the past ten years (40 quarters), AURX's ROE was at its highest in in the March 2018 quarter at 363.49%. The ROE was at its lowest in in the December 2017 quarter at -1656.17%.
Average
-147.61%
Median
22.18%
Minimum
-3102.01%
Maximum
1.88%
Discovering the peaks and valleys of Nuo Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 121.06%
Maximum Annual ROE = 1.88%
Minimum Annual Increase = -1882.36%
Minimum Annual ROE = -3102.01%
| Year | ROE | Change |
|---|---|---|
| 2024 | -452.34% | 48.21% |
| 2023 | -305.20% | 121.06% |
| 2022 | -138.06% | -895.63% |
| 2021 | 17.35% | -35.73% |
| 2020 | 27.00% | -90.29% |
| 2019 | 278.13% | -85.21% |
| 2018 | 1.88% | -160.62% |
| 2017 | -3102.01% | -1882.36% |
| 2016 | 174.04% | 20.48% |
| 2015 | 144.45% | -222.15% |
The current ROE of Nuo Therapeutics, Inc. (AURX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-298.53%
5-year avg
-170.25%
10-year avg
-147.61%
Nuo Therapeutics, Inc.’s ROE is greater than Kintor Pharmaceutical Limited (0%), greater than Paradigm Biopharmaceuticals Limited (-67.96%), greater than Poolbeg Pharma PLC (-53.86%), greater than Hofseth BioCare ASA (-279.05%), greater than Satellos Bioscience Inc. (-51.42%), less than VitaSpring Biomedical Co. Ltd. (128.70%), greater than Imugene Limited (-127.46%), greater than Green Growth Brands Inc. (-311.96%), less than AVITA Medical, Inc. (27.99%), greater than Starpharma Holdings Limited (-47.38%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $94.90M | |
| -67.96% | $109.88M | |
| -53.86% | $29.63M | |
| -279.05% | $66.68M | |
| -51.42% | $87.00M | |
| 128.70% | $207.03M | |
| -127.46% | $57.72M | |
| -311.96% | $2.06K | |
| 27.99% | $95.26M | |
| -47.38% | $99.94M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nuo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nuo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nuo Therapeutics, Inc.'s ROE?
How is the ROE calculated for Nuo Therapeutics, Inc. (AURX)?
What is the highest ROE for Nuo Therapeutics, Inc. (AURX)?
What is the 3-year average ROE for Nuo Therapeutics, Inc. (AURX)?
What is the 5-year average ROE for Nuo Therapeutics, Inc. (AURX)?
How does the current ROE for Nuo Therapeutics, Inc. (AURX) compare to its historical average?